巨子生物再跌超4% 可复美成分争议影响618销售 高盛下调公司业绩预测

智通财经
Jun 23, 2025

巨子生物(02367)再跌超4%,月内累跌近30%。截至发稿,跌3.71%,报49.35港元,成交额1.74亿港元。消息面上,5月24日,社交媒体上出现了针对巨子生物可复美重组胶原蛋白修护次抛精华中重组胶原蛋白含量标签的质疑。针对近期争议,华熙生物在回应媒体采访时强调,公司坚决反对在成分命名上玩“名称游戏”,并否认相关举措存在“商战”动机。此外,天猫大美妆发布618全周期美妆品牌排行榜,珀莱雅、...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10